Mirion Technologies (NYSE:MIR) Sets New 12-Month Low – Here’s What Happened

Mirion Technologies, Inc. (NYSE:MIR)’s stock price reached a new 52-week low on Wednesday. The stock traded as low as $14.08 and last traded at $14.3450, with a volume of 194176 shares trading hands. The stock had previously closed at $14.34.

Wall Street Analyst Weigh In

MIR has been the subject of several recent research reports. B. Riley Financial lowered their price target on Mirion Technologies from $29.00 to $27.00 and set a “buy” rating for the company in a report on Thursday, July 30th. Jefferies Financial Group started coverage on Mirion Technologies in a research note on Thursday, September 3rd. They set a “buy” rating and a $20.00 price objective on the stock. Morgan Stanley decreased their target price on Mirion Technologies from $27.00 to $25.00 and set an “equal weight” rating for the company in a research report on Monday, July 13th. Weiss Ratings upgraded Mirion Technologies from a “sell (d)” rating to a “hold (c)” rating in a research note on Monday, August 3rd. Finally, The Goldman Sachs Group reiterated a “buy” rating and set a $23.00 target price on shares of Mirion Technologies in a report on Wednesday, July 29th. One analyst has rated the stock with a Strong Buy rating, seven have issued a Buy rating and two have assigned a Hold rating to the stock. According to MarketBeat.com, the stock has an average rating of “Moderate Buy” and an average target price of $25.12.

Mirion Technologies Price Performance

The company has a debt-to-equity ratio of 0.64, a quick ratio of 2.63 and a current ratio of 3.20. The stock has a market cap of $3.62 billion, a price-to-earnings ratio of 145.60 and a beta of 1.05. The business’s fifty day simple moving average is $15.68 and its 200 day simple moving average is $17.34.

Mirion Technologies (NYSE:MIR) last announced its earnings results on Tuesday, July 28th. The company reported $0.12 earnings per share for the quarter, beating the consensus estimate of $0.10 by $0.02. Mirion Technologies had a return on equity of 6.59% and a net margin of 2.39%.The company had revenue of $266.80 million during the quarter, compared to the consensus estimate of $269.32 million. During the same period last year, the firm earned $0.11 earnings per share. The company’s revenue was up 19.7% on a year-over-year basis. Mirion Technologies has set its FY 2026 guidance at 0.480-0.550 EPS. Research analysts predict that Mirion Technologies, Inc. will post 0.55 EPS for the current fiscal year.

Institutional Investors Weigh In On Mirion Technologies

A number of hedge funds have recently bought and sold shares of MIR. Geode Capital Management LLC increased its holdings in Mirion Technologies by 2.8% during the 4th quarter. Geode Capital Management LLC now owns 5,786,596 shares of the company’s stock worth $135,545,000 after purchasing an additional 157,687 shares during the last quarter. Goldman Sachs Group Inc. boosted its stake in shares of Mirion Technologies by 3.8% during the 4th quarter. Goldman Sachs Group Inc. now owns 5,248,506 shares of the company’s stock valued at $122,920,000 after buying an additional 193,914 shares during the last quarter. Dimensional Fund Advisors LP boosted its stake in shares of Mirion Technologies by 14.4% during the 1st quarter. Dimensional Fund Advisors LP now owns 4,694,288 shares of the company’s stock valued at $87,240,000 after buying an additional 591,730 shares during the last quarter. Bank of New York Mellon Corp grew its position in shares of Mirion Technologies by 47.4% during the first quarter. Bank of New York Mellon Corp now owns 4,536,732 shares of the company’s stock worth $84,338,000 after buying an additional 1,459,787 shares in the last quarter. Finally, Maverick Capital Ltd. bought a new stake in shares of Mirion Technologies in the first quarter worth $49,261,000. Institutional investors and hedge funds own 78.51% of the company’s stock.

Mirion Technologies Company Profile

Mirion Technologies, Inc develops and provides radiation detection, measurement, and analysis solutions. Its products and services are used to monitor radiation, support nuclear safety, improve operational efficiency, and provide data for medical, industrial, scientific, and government applications.

The company’s offerings include radiation detectors, spectroscopy systems, dosimetry and personnel-monitoring solutions, radiation-monitoring equipment, and related software and services. In healthcare, Mirion provides technologies used in radiation therapy quality assurance, medical imaging, and radiation safety.